Current Issue : July-September Volume : 2014 Issue Number : 3 Articles : 3 Articles
In response to the growing needs for enhancing the effectiveness, safety, potency and preciseness of drug therapy, the profession of pharmacy is required to evolve new functions and responsibilities for practitioners of pharmacy. There is abundance of drug literature but a dearth of qualified pharmacist for effective selection, evaluation and utilization of drug literature and for dissemination and communication of existing drug information for use by health professionals. The clinical pharmacist can ensure that the patient understands the importance, nature and scope of the therapeutic plans being implemented and follows appropriate use of medication....
The ultimate goal of antihypertensive therapy is to reduce cardiovascular and renal morbidity and mortality.Most patients with hypertension require two or more antihypertensive medication to achieve the goal blood pressure. In this paper, we discussed the choice of antihypertensive drugs for specific patient groups....
The aim of the present study is to evaluate prescribing pattern and therapeutic outcomes in patients with dyslipidemia. A Prospective, observational study was carried out in the department of general medicine and cardiology for a period of one year in a tertiary care teaching hospital in south India after obtaining the ethical clearance. The patient data was collected by using a well designed questionnaire after taking their consent. The questionnaire was used to evaluate the prescribing pattern and asses the therapeutic outcome. A total of 80 patients were included, out of which 65 patients were males and 15 patients were females. 76 (95%) patients were on statins and 4(5%) patients were on combination therapy including a statin and a cholesterol absorption inhibitor or a fibrate or a nicotinic acid. Among the statin users atorvastatin was prescribed in 72(94.7%), Rosuvastatin in 5.2% of patients. In non coronary heart disease low risk group 83.75% achieved low density lipoprotein cholesterol goal. In high risk group 44.12% achieved the low density lipoprotein cholesterol goal. When the overall population is compared only 25% achieved the low density lipoprotein cholesterol goal. This study concludes that atorvastatin was prescribed in majority of study population. Achieving Low density lipoprotein cholesterol goal was observed in High risk <20% coronary heart disease risk category of the study population....
Loading....